一个有意义的功能衰退的预测,在肌缩性侧面硬化,基于多事件生存分析的功能衰退
Christian Marius Lillelund1,2, Sanjay Kalra1,3,4, Russell Greiner1,5
1Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada.
PloS one
|November 18, 2025
概括
这项研究引入了一种新方法,用于预测肌缩侧面硬化症 (ALS) 患者的功能衰退,帮助个性化治疗规划. 该方法预测特定功能障碍的时间,以便制定更好的医疗干预策略.
科学领域:
- 神经学 神经学
- 生物统计学 生物统计学
- 医疗信息学 医疗信息学
背景情况:
- 肌缩侧面硬化 (ALS) 是一种进展性神经退行性疾病,影响运动神经元,导致.
- 目前的治疗方法侧重于延长生存时间和改善生活质量,但疾病异质性使介入的最佳时间变得复杂.
- 预测显著功能障碍的出现对于个性化患者管理至关重要.
研究的目的:
- 开发和验证一种新的方法,用于预测ALS患者显著功能障碍的时间.
- 为关键功能创建特定事件的个人生存分布 (ISD):说话,吞,手写,行走和呼吸.
- 为评估干预措施和患者特征的影响提供反事实预测.
主要方法:
- 制定了预测任务作为一个多事件生存问题.
- 使用PRO-ACT数据集训练了五种基于共变量的生存模型.
- 预测每个患者的五个特定事件的个人生存分布 (ISD).
主要成果:
- 基于共变量的模型在预测时间到事件结果方面表现优于卡普兰-梅尔估计器.
- 利鲁对预测的功能衰退的影响很小.
- 预测,腹发病的ALS患者会比肢体发病的患者显著更快地出现言语和吞能力的下降.
结论:
- 拟议的方法提供了一个可靠的工具,用于评估ALS的功能衰退风险.
- 个性化预测可以为个性化治疗规划和干预时间提供信息.
- 该模型根据发病类型突出了疾病进展的差异,有助于有针对性的护理.
相关概念视频
01:15Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388
01:21Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
01:18Introduction To Survival Analysis
718
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
718
01:20Actuarial Approach
280
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
280
01:20Comparing the Survival Analysis of Two or More Groups
541
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
541
01:24Kaplan-Meier Approach
541
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
541